Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
Partner Content Partner Content Pain Therapeutics: Interviews AstraZeneca, Ensysce Bioscienc... Pain Therapeutics Exclusive Speaker Interviews Released
News Regenxbio, Solid report data with Duchenne gene therapies Regenxbio and Solid Bio say their gene therapies for Duchenne muscular dystrophy show no sign so far of the liver issues seen with Sarepta's Elevidys.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
